| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
10,221 |
10,100 |
$632K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
4,789 |
4,358 |
$195K |
| 92083 |
|
4,582 |
4,546 |
$188K |
| 92250 |
|
6,760 |
6,623 |
$176K |
| 92273 |
|
2,700 |
2,635 |
$176K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,676 |
2,171 |
$145K |
| 92235 |
|
2,433 |
2,305 |
$138K |
| 68761 |
|
1,511 |
836 |
$109K |
| J0178 |
Injection, aflibercept, 1 mg |
279 |
205 |
$108K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,164 |
1,150 |
$94K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
837 |
824 |
$73K |
| 92020 |
|
4,582 |
4,515 |
$67K |
| J9035 |
Injection, bevacizumab, 10 mg |
929 |
755 |
$45K |
| 92134 |
|
2,982 |
2,714 |
$41K |
| 92133 |
|
1,621 |
1,609 |
$37K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
78 |
53 |
$37K |
| 67228 |
|
138 |
123 |
$29K |
| 76512 |
|
803 |
600 |
$24K |
| 92226 |
|
1,253 |
937 |
$16K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
32 |
24 |
$13K |
| 92015 |
Determination of refractive state |
846 |
838 |
$12K |
| 92202 |
|
1,567 |
1,488 |
$10K |
| 92287 |
|
21 |
21 |
$2K |
| 68801 |
|
60 |
24 |
$2K |
| 76514 |
|
190 |
187 |
$1K |
| 92132 |
|
68 |
66 |
$1K |
| 92225 |
|
16 |
13 |
$245.88 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
192 |
156 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
317 |
274 |
$0.00 |